BeiGene, Ltd. announced the appointment of Giancarlo Benelli as Senior Vice President and Head of Europe, effective January 1. This appointment will enhance the Company?s commitment to bring impactful medicines to more patients across Europe. Mr. Benelli is a global executive with over 20 years of experience in the pharmaceutical industry including at Novartis and AstraZeneca. He was most recently Vice President and Head Radioligand Therapy International Markets at Novartis.
Prior to his role as Head Radioligand Therapy International Markets at Novartis, Mr. Benelli served as General Manager at Advanced Accelerators Applications, where his responsibilities included restructuring the manufacturing, R&D, and commercial organizations in Saint Genis Poully post-Adacap acquisition by Novartis, ensuring business continuity and successfully launching Lutathera in both France and Italy amid post-merger challenges. Mr. Benelli received a Medical Doctorate degree and a Post Graduate Diploma in Thoracic Surgery, both from University of Genoa, Italy and a Diploma in Health Economics from the University of York, UK.